More than 50 people were displaced following a three-alarm fire at an apartment building in Groton on Sunday that left two firefighters injured and drew a massive response from fire departments across ...
Lilly's triple agonist, retatrutide, delivered powerful weight loss in pivotal Phase 3 obesity trial
iPercent body weight reduction with retatrutide 4 mg was a key secondary endpoint. iiThe extension period enrolled 532 participants with BMI ≥35 at baseline who had completed the main 80-week study ...
Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The ...
SAO PAULO, May 19 (Reuters) - Brazil's Finance Ministry on Tuesday released a preliminary proposal for phased sectoral coverage of the country's regulated carbon market, outlining which industries ...
When you order a new broadcast transmitter, one of the first questions will be about power. Is it single-phase or three-phase alternating current? If single-phase, it is 208 or 240 volts? If it is ...
Connecticut officials say progress has been made on the Interstate 91 project near Meriden, but construction is far from complete. The Connecticut Department of Transportation said the project began ...
The system integrates a battery, hybrid inverter, and home energy management system into a single device. It supports the integration of additional appliances, including heat pumps via SG-Ready ...
MONTRÉAL--(BUSINESS WIRE)--Triple Hair Group Inc. (“Triple Hair” or the “Company”), a company specializing in the development of innovative treatments for androgenic alopecia (pattern baldness), today ...
Phase III trial to enroll 420 men across up to 10 clinical sites in Canada First patient has now been dosed in the Company’s Phase III trial evaluating TH07 TH07 is a patented prescription ...
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...
A pre-specified interim analysis showed dual primary endpoint success, with improved PFS and OS versus physician’s-choice chemotherapy in taxane-progressed advanced TNBC. BL-B01D1-307 was a randomized ...
Novo Nordisk and its Chinese partner have reported up to 19.7% weight loss in patients who took their triple agonist for 24 weeks, illuminating a potential path forward for the Danish drugmaker as it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results